SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Tóth AR, Kovács K, Árok Z, Varga T, Kereszty, Institóris L. Rom. J. Leg. Med. 2013; 21(4): 275-280.

Copyright

(Copyright © 2013, Romanian Legal Medicine Society)

DOI

10.4323/rjlm.2013.275

PMID

unavailable

Abstract

The role of stimulant designer drug consumption has been investigated in three fatal cases. In Case 1 the fatal outcome can be attributed to the come down phase following their application, as the blood and urine concentration of the designer drugs was low. In the second case arrhythmogenic effect of methylone was added to the right ventricular arrhythmogenic dysplasia of the patient and these two factors could lead to death. The suicide case (Case 3) was probably the consequence of the withdrawal effect of MDPV (methylenedioxypyrovalerone). The aim of this issue was to focus on some questions of forensic importance that arose in three autopsy cases where the consumption of amphetamine-like designer drugs could play a role in the fatal outcome. © 2013 Romanian Society of Legal Medicine.


Language: en

Keywords

adolescent; adult; human; suicide; Autopsy; male; autopsy; Hungary; case report; traffic accident; drug use; amphetamine; toxicology; article; unclassified drug; brain edema; drug blood level; drug urine level; methamphetamine; fatality; 3,4 methylenedioxymethamphetamine; codeine; lung edema; Glasgow coma scale; metabolic acidosis; GC-MS analysis; central stimulant agent; unconsciousness; designer drug; outcome assessment; medical history; heart right ventricle dysplasia; young adult; methylenedioxypyrovalerone; methylone; 3,4 dimethylmethcathinone; 4 fluoromethcathinone; Amphetamine-like designer drugs; Fatal cases; limit of detection; limit of quantitation

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print